Status
Conditions
Treatments
About
The purpose of this study is to investigate the effects of a training program in patients that have suffered a COVID infection
Full description
Once patients have been selected and meet inclusion criteria, they will sign informed consent. They will make a first visit to obtain the basal parameters. Once done, they will start the individualized training program for 12 weeks 3 times a week.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Men and women ≥18 years
Patients discharged from the Pulmonology Service with a diagnosis of COVID-19 by positive PCR and with severe pneumonia.
At least three months after the presence of at least one of the following criteria:
MRC dyspnea greater than or equal to 2.
Decrease in the meters walked with respect to the reference values in the 6-minute walking test.
C) Decreased respiratory muscle strength measured at Maximum Inspiratory Pressure (PIM) and / or Maximum Expiratory Pressure (PEM) with respect to reference values.
Sign informed consent from the study
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
24 participants in 2 patient groups
Loading...
Central trial contact
Gerard Muñoz, PhD; Gladis Sabater, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal